PTPN14 and skin basal cell carcinoma: The identification of inactivating mutations in two key components of the Hippo–YAP pathway, LATS1 and PTPN14 genes, provides clear evidence of the involvement of this signaling cascade in BCC, adding BCC to the broad group of human cancers with a deregulated Hippo–YAP axis.